"Retina Consultants of Texas provides world-class retina care to patients across Houston. Visit our retina center in The Woodlands to get top retina specialist care for wet & dry macular degeneration (AMD), diabetic retinopathy, retinal tears & detachments, uveitis, flashes & floaters, and more. We offer a full spectrum of retinal diagnostics (fluorescein angiography, etc.) and treatments such as eye injections (Avastin, Lucentis, Eylea), vitrectomy, and scleral buckle. Our retina research center is the largest in the country. We participate in many cutting-edge clinical trials for new & improved retina care. Our retina center in The Woodlands is easily accessible for patients in Conroe, Navasota, Spring, Pinehurst, and beyond."

During the past decade, Retina Consultants of Houston conducted 56 clinical trials. In the 10-year time frame, 56 clinical trials started and 18 clinical trials were completed, i.e. on average, 32.1% percent of trials that started reached the finish line to date. In the past 5 years, 36 clinical trials started and 14 clinical trials were completed. i.e. 38.9% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Retina Consultants of Houston" #1 sponsor was "Hoffmann-La Roche" with 13 trials, followed by "Clearside Biomedical, Inc." with 6 trials sponsored, "Kodiak Sciences Inc" with 4 trials sponsored, "Apellis Pharmaceuticals, Inc." with 3 trials sponsored and "Charles C Wykoff, PhD, MD" with 3 trials sponsored. Other sponsors include 26 different institutions and companies that sponsored additional 27 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Retina Consultants of Houston" #1 collaborator was "Regeneron Pharmaceuticals" with 5 trials as a collaborator, "Genentech, Inc." with 4 trials as a collaborator, "Chugai Pharmaceutical" with 2 trials as a collaborator, "Novartis Pharmaceuticals" with 2 trials as a collaborator and "Parexel" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 7 trials.

According to Clinical.Site data, the most researched conditions in "Retina Consultants of Houston" are "Geographic Atrophy" (10 trials), "Macular Degeneration" (8 trials), "Diabetic Macular Edema" (6 trials), "Diabetic Retinopathy" (6 trials) and "Neovascular Age-related Macular Degeneration" (6 trials). Many other conditions were trialed in "Retina Consultants of Houston" in a lesser frequency.

Most popular intervention types in "Retina Consultants of Houston" are "Drug" (50 trials), "Other" (15 trials), "Procedure" (7 trials), "Biological" (4 trials) and "Device" (3 trials). Other intervention types were less common.

The name of intervention was led by "Sham Procedure" (12 trials), "Aflibercept" (11 trials), "Ranibizumab" (6 trials), "Faricimab" (5 trials) and "Placebo" (5 trials). Other intervention names were less common.

The vast majority of trials in "Retina Consultants of Houston" are 60 trials for "All" genders.

Currently, there are NaN active trials in "Retina Consultants of Houston". undefined are not yet recruiting, 9 are recruiting, 18 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 24 completed trials in Retina Consultants of Houston, undefined suspended trials, and 6 terminated clinical trials to date.

Out of the total trials that were conducted in Retina Consultants of Houston, 8 "Phase 1" clinical trials were conducted, 26 "Phase 2" clinical trials and 22 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 3 trials, and there were also 1 trials that are defined as “Not Applicable".